Kathleen McElhone
University of Manchester(GB)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Systemic Lupus Erythematosus Research, Pharmaceutical studies and practices, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)(2015)366 cited
- → Development and validation of a disease‐specific health‐related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus(2007)338 cited
- → A review of health related quality of life in systemic lupus erythematosus(2006)288 cited
- → Psychological Distress Impairs Clearance of Psoriasis in Patients Treated With Photochemotherapy(2003)243 cited
- → HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis(2018)169 cited
- → Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis(2022)140 cited
- → Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study(2010)123 cited
- → Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study(2001)120 cited
- → The British Association of Dermatologists’ Biologic Interventions Register (BADBIR): design, methodology and objectives(2012)119 cited
- → Demographics and disease characteristics of patients with psoriasis enrolled in theBritishAssociation ofDermatologistsBiologicInterventionsRegister(2015)106 cited